Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature
Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-01-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/10/1/13 |
| _version_ | 1827653261523419136 |
|---|---|
| author | Mary Elkomos Raha Jahromi Michael S. Kelly |
| author_facet | Mary Elkomos Raha Jahromi Michael S. Kelly |
| author_sort | Mary Elkomos |
| collection | DOAJ |
| description | Statins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations should receive statin therapy, a substantial portion of eligible patients are not prescribed statin therapy. Pharmacists have attempted to increase the number of eligible patients receiving appropriate statin therapy through a variety of interventions and across several clinical settings. In this article, we highlight multiple studies evaluating the effectiveness of pharmacist-led interventions to improve statin use. A total of seven studies were selected for this narrative review, demonstrating the effectiveness and barriers of different statin-initiation programs delivered by pharmacists to increase statin use in eligible patients. Among the interventions assessed, a combination of provider communicating and statin prescribing through collaborative drug therapy management (CDTM) appear to the be the most useful at increasing statin use. Pharmacists can significantly improve statin use rates among eligible patients through multiple intervention types and across different clinical settings. Further studies should evaluate continued statin adherence and clinical outcomes among patients served by pharmacists. |
| first_indexed | 2024-03-09T21:14:31Z |
| format | Article |
| id | doaj.art-f0c736ae362440a88cdcc118c8876335 |
| institution | Directory Open Access Journal |
| issn | 2226-4787 |
| language | English |
| last_indexed | 2024-03-09T21:14:31Z |
| publishDate | 2022-01-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmacy |
| spelling | doaj.art-f0c736ae362440a88cdcc118c88763352023-11-23T21:40:02ZengMDPI AGPharmacy2226-47872022-01-011011310.3390/pharmacy10010013Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the LiteratureMary Elkomos0Raha Jahromi1Michael S. Kelly2Chapman University School of Pharmacy, Irvine, CA 92618, USAChapman University School of Pharmacy, Irvine, CA 92618, USADepartment of Pharmacy Practice, Chapman University School of Pharmacy, Irvine, CA 92618, USAStatins are lipid-lowing medications shown to reduce cardiovascular events and are recommended for specific patient populations at elevated risk of atherosclerotic cardiovascular disease (ASCVD). Despite the demonstrated efficacy of statins for reducing ASCVD risk, and guidance on which populations should receive statin therapy, a substantial portion of eligible patients are not prescribed statin therapy. Pharmacists have attempted to increase the number of eligible patients receiving appropriate statin therapy through a variety of interventions and across several clinical settings. In this article, we highlight multiple studies evaluating the effectiveness of pharmacist-led interventions to improve statin use. A total of seven studies were selected for this narrative review, demonstrating the effectiveness and barriers of different statin-initiation programs delivered by pharmacists to increase statin use in eligible patients. Among the interventions assessed, a combination of provider communicating and statin prescribing through collaborative drug therapy management (CDTM) appear to the be the most useful at increasing statin use. Pharmacists can significantly improve statin use rates among eligible patients through multiple intervention types and across different clinical settings. Further studies should evaluate continued statin adherence and clinical outcomes among patients served by pharmacists.https://www.mdpi.com/2226-4787/10/1/13pharmacist providerstatinsstatin-use measuresvalue-based outcomespopulation health |
| spellingShingle | Mary Elkomos Raha Jahromi Michael S. Kelly Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature Pharmacy pharmacist provider statins statin-use measures value-based outcomes population health |
| title | Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature |
| title_full | Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature |
| title_fullStr | Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature |
| title_full_unstemmed | Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature |
| title_short | Pharmacist-Led Programs to Increase Statin Prescribing: A Narrative Review of the Literature |
| title_sort | pharmacist led programs to increase statin prescribing a narrative review of the literature |
| topic | pharmacist provider statins statin-use measures value-based outcomes population health |
| url | https://www.mdpi.com/2226-4787/10/1/13 |
| work_keys_str_mv | AT maryelkomos pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature AT rahajahromi pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature AT michaelskelly pharmacistledprogramstoincreasestatinprescribinganarrativereviewoftheliterature |